Patent foramen ovale: The never-ending story

Current Treatment Options in Cardiovascular Medicine

Volumn 7, Issue 3, 2005, Pages 227-239

  Devuyst, Gérald ^a   Bogousslavsky, Julien ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AGE; ANAMNESIS; ANEURYSM; BLEEDING; BRAIN EMBOLISM; CLINICAL PRACTICE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG SUBSTITUTION; ECHOCARDIOGRAPHY; HEART ATRIUM SEPTUM; HEART ATRIUM SEPTUM DEFECT; HEMOSTASIS; HUMAN; HYPERTENSION; LUNG EMBOLISM; MEDICAL RESEARCH; MIGRAINE; MINIMALLY INVASIVE SURGERY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PSYCHOLOGICAL ASPECT; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; RISK FACTOR; SAFETY; SECONDARY PREVENTION; ST SEGMENT ELEVATION; STROKE; SURGICAL TECHNIQUE; THROMBOSIS; VEIN THROMBOSIS;

EID: 27744528182     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-005-0051-x     Document Type: Review

References (81)

1. Lechat P, Mas JL, Lascault G, et al.: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988, 318:1148-1152.
2. Overell JR, Bone I, Lees KR: Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000, 55:1172-1179.
3. Di Tullio M, Sacco RL, Gopal A, et al.: Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992, 117:461-465.
4. Mas JL, Arquizan C, Lamy C, et al.: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001, 345:1740-1746.
5. Moon RE, Camporese EM, Kisslo JA: Patent foramen ovale and decompression sickness in divers. Lancet 1989, 1:513-514.
6. Wilmshurst PT, Byrne JC, Webb-People MM: Relation between interatrial shunts and decompression sickness in divers. Lancet 1989, 2:1302-1306.
7. Del Sette M, Angeli S, Leandri M: Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998, 8:327-330.
8. Anzola GP, Mangoni M, Guindani M, et al.: Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999, 52:1622-1625.
9. Forech C, Kessler KF, Steinmets H, et al.: "Economy class" stroke syndrome. Neurology 2004, 62:1026.
10. Conheim J: Thrombose und embolie. In Vorlesungen über Allgemein Pathologie, vol 1. Berlin: Hirschwald; 1877:134.
11. Zahn FW: Thrombose de plusieurs branches de la veine cave inférieure avec embolies consécutives dans les artères pulmonaires, spléniques, rénales et iliaque droite. Rev Med Suisse Romande 1881, 1:227-237.
12. Hagen PT, Scholz DG, Edwards WD, et al.: Incidence and size of patent foramen ovale during the first ten decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984, 59:17-20.
13. Thompson T, Evans W: Paradoxical embolism. Q J Med 1930, 23:135-150.
14. Meissner I, Whisnant JP, Khandheria BK, et al.: Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc 1999, 74:862-869.
15. Agmon y, Khandheria BK, Messner I, et al.: Comparison of frequency of patent foramen ovale by transesophageal echocardiography in patients with cerebral ischemic events versus in subjects in the general population. Am J Cardiol 2001, 88:330-332.
16. Hart RG, Albers GW, Koudstaal PJ: Cardioembolic stroke. In Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management, vol 2. Edited by Ginsberg MD, Bogousslavsky J. Oxford: Blackwell Publishers; 1998:1392-1429.
17. Kerut EK, Norfleet WT, Plotnick GD, et al.: Patent foramen oval: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001, 38:613-623.
18. Schneider B, Harath P, Vogel P, et al.: Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol 1990, 16:1000-1009.
19. Homma S, Sacco RL, Di Tullio MF, et al.: Relationship of atrial septal aneurysm with patent foramen ovale: insights from PFO in Cryptogenic Stroke Study (PICSS). Circulation 2001, 104(suppl 2):670.
20. Fox ER, Picard MH, Chow CM, et al.: Interatrial septal mobility predicts larger shunts across patent foramen ovales: an analysis with transmitral Doppler scanning. Am Heart J 2003, 145:730-736.
21. Homma S, Sacco RL, Di Tullio MR, et al.: Atrial anatomy in non-cardioembolic stroke patients. Effect of medical therapy. J Am Coll Cardiol 2003, 42:1066-1072.
22. Webster MW, Chancellor AM, Smith HJ, et al.: Patent foramen ovale in young stroke patients. Lancet 1988, 2:1-12.
23. Pearson AC, Nagelhout D, Castello R, et al.: Atrial septal aneurysm and stroke: a transesophageal echocardiography. J Am Coll Cardiol 1991, 18:1223-1229.
24. Cabanes L, Mas JL, Cohen A, et al.: Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patient with less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993, 24:1865-1873.
25. Agmon Y, Khandhheria BK, Meissner I, et al.: Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999, 99:1942-1944.
26. Mattioli AV, Aquilina M, Oldani A, et al.: Atrial septal aneurysm as a cardioembolic source in adults patients with stroke and normal arteries. A multicentric study. Eur Heart J 2001, 22:261-268.
27. Chen WJ, Lin SL, Cheng JJ, et al.: The frequency of patent foramen ovale in patients with ischemic stroke: a transesophageal echocardiographic study. J Formos Med Assoc 1991, 90:744-748.
28. Job FP, Ringelstein EB, Grafen Y, et al.: Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 1994, 74:381-384.
29. Jones HR, Caplan LR, Come PC, et al.: Cerebral emboli of paradoxical origin. Ann Neurol 1983, 13:314-319.
30. Zahn R, Lehmkuhl S, Lotter R, et al.: Cardiac sources of cerebral ischemic events with special regard to a patent foramen ovale. Herz Kreislauf 1995, 27:279-284.
31. de Belder MA, Tourikis L, Leech G, et al.: Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992, 69:1316-1320.
32. Meister SG, Grossman W, Dexter L, Dalen JE: Paradoxical embolism. Diagnosis during life. Am J Med 1972, 53:292-298.
33. Holmes DR, Cohen H, Katz WE, et al.: Patent foramen oval, systemic embolization and closure. Cur Probl Cardiol 2004, 29:56-94.
34. d'Audiffret A, Pillai L, Dryjski M, et al.: Paradoxical emboli: the relationship between patent foramen ovale, deep vein thrombosis and ischaemic stroke. Eur j Vasc Endovasc Surg 1999, 17:468-471.
35. Mas JL: Specifics of patent foramen ovale. In Ischemic Stroke (Advances in Neurology), vol 92. Edited by Barnett et al. Philadelphia: Lippincott, Williams & Wilkins; 2003:197-202.
36. Stöllberger C, Slany J, Schuster I, et al.: The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993, 119:461-465.
37. Stöllberger C, Finsterer J: Search for coagulopathy does not obviate search for venous thrombosis in suspected paradoxical embolism. Stroke 2003, 34:28-33.
38. Lethen H, Flachskampf FA, Schneider R, et al.: Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997, 80:1066-1069.
39. Ranoux D, Cohen MD, Cabanes L, et al.: Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 1993, 1:193-202.
40. Perrier A: Labeling the thrombus. The future of nuclear medicine for venous thromboembolism? Am J Respir Crit Care Med 2004, 169:977-981.
41. Morris TA, Marsh JJ, Chiles PG, et al.: Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-Dimer. Am J Respir Crit Care Med 2004, 169:987-993.
42. Reid JH: Multislice CT pulmonary angiography and CT venography. Br J Radiol 2004, 77:S39-S45.
43. Morandi E, Anzola GP, Angeli S, et al.: Transcatheter closure of patent foramen ovale: a new migraine treatment? J Int Cardiol 2003, 16:39-42.
44. Sztajzel R, Genoud D, Roth S, et al.: Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002, 13:102-106.
45. Hayashida K, Fukuchi K, Inubushi M, et al.: Embolic distribution through patent foramen ovale demonstrated by 99mTc-MAA brain SPECT after Valsalva radionuclide venography. J Nucl Med 2001, 42:859-863.
46. Gupta VK: Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004, 63:1760-1761; author reply 1760-1.
47. Post MC, Thijs V, Herroelen L, et al.: Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004, 62:1439-1440.
48. Schwerzmann M, Wiher S, Nedeltchev K, et al.: Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004, 62:1399-1401.
49. Messé SP, Silverman IE, Kizer JR, at al.: Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2004, 62:1042-1050.
50. Bogousslavsky J, Garazi S, Jeanrenaud X, et al.: Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with paradoxical embolism study group. Neurology 1996, 46:1301-1305.
51. De Castro S, Cartoni D, Fiorelli M, et al.: Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000, 31:2407-2413.
52. Homma S, De Sacco RL, Di Tullio MR, et al.: Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study (PICSS). Circulation 2002, 105:2625-2631.
53. Homma S, Di Tullio MR, Sacco RL, et al.: Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994, 25:582-586.
54. Steiner MM, Di Tullio MR, Rundek T, et al.: Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998, 29:944-948.
55. Serena J, Segura T, Perez-Ayuso MJ, et al.: The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke 1998, 29:1322-1328.
56. Anzola GP, Zavarize P, Morandi E, et al.: Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. Eur J Neurol 2003, 10:129-135.
57. Schuchlenz HW, Weihs W, Horner S, et al.: The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000, 109:456-462.
58. Devuyst G, Piechowski-Jozwiak B, Karapanayiotides T, et al.: Controlled contrast transcranial Doppler and arterial blood gas analysis to quantify shunt through patent foramen ovale. Stroke 2004, 35:859-863.
59. Homma S, Di Tullio M, Sacco L, et al.: Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke 2004, 35:2145-2149.
60. Ringelstein EB, Droste DW, Babikian VL, et al.: Consensus on microembolus detection by TCD. Stroke 1998, 29:725-729.
61. Jauss M, Zanette E: Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 2000, 10:490-496.
62. Spencer MP, Moehring MA, Jesurum J, et al.: Power M-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging 2004, 14:342-349.
63. Furlan AJ: Patent foramen ovale and recurrent stroke: closure is the best option: yes. Stroke 2004, 35:803-804.
64. Tong DC, Becker KJ: Patent foramen ovale and recurrent stroke: closure is the best option:no. Stroke 2004, 35:803-804.
65. Devuyst G, Bogousslavsky J, Ruchat P, et al.: Prognosis after stroke followed by surgical closure of patent foramen ovale. a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996, 47:1162-1166.
66. Homma MR, Di Tullio RL, Sacco RR, et al.: Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997, 28:2376-2381.
67. Dearani JA, Ugurlu BS, Danielson GK, et al.: Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999, 100:II171-II175.
68. Caes FL, Van Belleghem YV, Missault LH: Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg 1995, 59:1559-1561.
69. Levi DS, Moore JW. Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 2004, 61:543-547.
70. Windecker S, Wahl A, Chatterjee T, et al.: Percutaneous closure of PFO in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000, 101:893-898.
71. Braun MU, Fassbender D, Schoen SP, et al.: Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002, 39:2019-2025.
72. Onorato E, Melzi G, Casilli F, et al.: Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure of 256 patients. J Int Cardiol 2003, 16:43-50.
73. Sievert H, Horvath K, Zadan E, et al.: Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Int Cardiol 2001, 14:261-266.
74. Bruch L, Parsi A, Grad MO, et al.: Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 2002, 105:2845-2848.
75. Hung J, Landzberg MJ, Jenkins KJ, et al.: Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000, 35:1311-1316.
76. Martin F, Sanchez PL, Doherty E, et al.: Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002, 106:1121-1126.
77. Schwerzmann M, Windecker S, Wahl A, et al.: Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004, 90:186-190.
78. Ferrari J, Baumgartner H, Tentschert S, et al.: Cerebral microembolism. during transcatheter closure of patent foramen ovale. J Neurol 2004, 251:825-829.
79. Khositseth A, Calabra AK, Sweeney JP, et al.: Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc 2004, 79:35-41.
80. Hildick-Smith DJ, O'Sullivan M, Wisbey CR, et al.: Amplatzer device closure of atrial septal defects in mature adults: analysis of 76 cases. Heart 2004, 90:334-335.
81. Anzola GP, Morandi E, Casilli F, et al.: Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler. Stroke 2004, 35:2140-2144.